Skip to main content
Premium Trial:

Request an Annual Quote

BGI Bolsters Stock of Illumina Sequencers

NEW YORK (GenomeWeb News) – The Beijing Genomics Institute has purchased 12 new Genome Analyzers for use in its Hong Kong and Shenzhen research centers, the company said today.

BGI will use the new sequencing capacity to support its ongoing and planned programs, including the 1000 Genomes Project, the Chinese Cancer Genome project, the Tree of Life Project, and other agriculture, biomedical, and biofuel research programs.

Eight of the sequencers will be installed in BGI's Hong Kong facility and four will be used in studies at its Shenzhen labs. Financial terms of the purchase were not released.

BGI, which has seven branches in China, one in the US, and one in Europe, will now have a total of 29 of these next generation Illumina analyzers.

In addition to its research programs, BGI offers sequencing services to the international community.